NCT06680167View on ClinicalTrials.gov

Hyperbaric Prilocaine 2% vs Hyperbaric Bupivacaine 0.5% in Caesarean Section

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

November 5, 2025

Study Completion Date

December 31, 2025

Conditions
Spinal Anesthesia
Interventions
DRUG

Spinal anesthesia (heavy bupivacaine 0.5%)

12.5mg of Heavy bupivacaine 0.5% will be injected intrathecally for women undergoing elective caesarean section

DRUG

spinal anesthesia (hyperbaric Prilocaine 2%)

60mg of Hyperbaric Prilocaine 2% will be injected intrathecally for women undergoing elective caesarean section

Trial Locations (1)

82749

Sohag University Hospitals, Sohag

All Listed Sponsors
lead

Sohag University

OTHER